Coverage for pharmacogenomic testing hinges on your insurer
Imagine two patients sitting in the same clinic. They have the same diagnosis, are being considered for the same medication, and have the same clinical reason for drug-gene (also known as pharmacogenomic, or PGx) testing. For one patient, the test…
Imagine two patients sitting in the same clinic. They have the same diagnosis, are being considered for the same medication, and have the same clinical reason for drug-gene (also known as pharmacogenomic, or PGx) testing. For one patient, the test is covered. For the other, it is not. The difference may have little to do with the clinical evidence. It may come down to their insurance.
That is the access problem …
Coverage for pharmacogenomic testing hinges on your insurer
